Lori Winkler, who serves as senior vice president and chief human resources officer at Zimmer Biomet Holdings, Inc. (NYSE:ZBH), completed a sale of company stock on March 12, 2026. According to the filing, Winkler sold 2,650 shares of common stock at $94.66 per share, producing total gross proceeds of $250,849.
Following this disposition, Winkler is recorded as directly owning 10,224 shares of Zimmer Biomet common stock. The filing does not provide additional context for the sale.
That insider transaction arrives while the company has recently reported results and received renewed analyst attention. Zimmer Biomet posted fourth-quarter earnings that exceeded analyst expectations. Management paired that earnings beat with a cautious outlook for 2026, a stance described as reflective of the company’s strategic considerations for the year ahead.
Separately, William Blair initiated coverage of Zimmer Biomet and assigned a Market Perform rating. In its initiation note, the firm highlighted the company’s multi-year efforts to broaden its product array and deepen its development pipeline, noting that those efforts have included divestitures and tuck-in acquisitions over the past five years. William Blair framed these actions as initiatives intended to accelerate revenue growth and said it appreciated the company’s focus on strengthening its market position.
Taken together, the insider sale, the stronger-than-expected quarterly results, the cautious 2026 outlook and the new analyst coverage give investors several recent data points about Zimmer Biomet’s current performance and management priorities. The filings and analyst commentary cited here provide information on recent transactions and corporate strategy, but do not include guidance beyond the statements referenced above.
All figures and assertions in this report are drawn from the company’s disclosures and the analyst initiation referenced in the filings.